| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |